Chemed Corp. Company Profile (NYSE:CHE)

About Chemed Corp. (NYSE:CHE)

Chemed Corp. logoChemed Corporation purchases, operates and divests subsidiaries engaged in various business activities. The Company operates through two segments: the VITAS segment (VITAS) and the Roto-Rooter segment (Roto-Rooter). The Company's VITAS provides hospice and palliative care services to its patients through a network of physicians, registered nurses, home health aides, social workers, clergy and volunteers. VITAS is the provider of hospice services in an industry dominated primarily by small, non-profit, community-based hospices. VITAS provides hospice care to Medicare beneficiaries participating in these managed care programs. A portion of its VITAS business is operated in the state of Florida. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration and other related services to both residential and commercial customers.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Healthcare Facilities & Services - NEC
  • Sub-Industry: Health Care Services
  • Symbol: NYSE:CHE
  • CUSIP: 16359R10
  • Web:
  • Market Cap: $3.26 billion
  • Outstanding Shares: 16,082,000
Average Prices:
  • 50 Day Moving Avg: $205.37
  • 200 Day Moving Avg: $189.24
  • 52 Week Range: $130.05 - $216.01
  • Trailing P/E Ratio: 29.73
  • Foreward P/E Ratio: 23.93
  • P/E Growth: 2.56
Sales & Book Value:
  • Annual Revenue: $1.59 billion
  • Price / Sales: 2.05
  • Book Value: $31.13 per share
  • Price / Book: 6.51
  • Annual Dividend: $1.04
  • Dividend Yield: 0.5%
  • EBIDTA: $217.5 million
  • Net Margins: 7.14%
  • Return on Equity: 24.62%
  • Return on Assets: 14.04%
  • Debt-to-Equity Ratio: 0.27%
  • Current Ratio: 1.07%
  • Quick Ratio: 1.04%
  • Average Volume: 101,902 shs.
  • Beta: 1.15
  • Short Ratio: 16.02
Frequently Asked Questions for Chemed Corp. (NYSE:CHE)

What is Chemed Corp.'s stock symbol?

Chemed Corp. trades on the New York Stock Exchange (NYSE) under the ticker symbol "CHE."

How often does Chemed Corp. pay dividends? What is the dividend yield for Chemed Corp.?

Chemed Corp. announced a quarterly dividend on Monday, May 15th. Stockholders of record on Thursday, May 25th will be paid a dividend of $0.26 per share on Wednesday, June 14th. This represents a $1.04 annualized dividend and a dividend yield of 0.51%. The ex-dividend date of this dividend is Tuesday, May 23rd. View Chemed Corp.'s Dividend History.

How will Chemed Corp.'s stock buyback program work?

Chemed Corp. declared that its Board of Directors has approved a share repurchase program on Monday, April 10th 2017, which authorizes the company to buyback $100,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization authorizes the company to purchase up to 3.3% of its stock through open market purchases. Stock buyback programs are often an indication that the company's management believes its stock is undervalued.

How were Chemed Corp.'s earnings last quarter?

Chemed Corp. (NYSE:CHE) announced its quarterly earnings results on Wednesday, April, 26th. The company reported $1.82 EPS for the quarter, beating the consensus estimate of $1.78 by $0.04. The company earned $405.90 million during the quarter, compared to analysts' expectations of $399.75 million. Chemed Corp. had a return on equity of 24.62% and a net margin of 7.14%. The business's revenue for the quarter was up 4.0% on a year-over-year basis. During the same period in the previous year, the firm earned $1.62 earnings per share. View Chemed Corp.'s Earnings History.

When will Chemed Corp. make its next earnings announcement?

Chemed Corp. is scheduled to release their next quarterly earnings announcement on Tuesday, July, 25th 2017. View Earnings Estimates for Chemed Corp..

What guidance has Chemed Corp. issued on next quarter's earnings?

Chemed Corp. updated its FY17 earnings guidance on Wednesday, April, 26th. The company provided EPS guidance of $7.80-$8.00 for the period, compared to the Thomson Reuters consensus EPS estimate of $7.90.

Where is Chemed Corp.'s stock going? Where will Chemed Corp.'s stock price be in 2017?

3 equities research analysts have issued 12 month price targets for Chemed Corp.'s stock. Their forecasts range from $155.00 to $208.00. On average, they expect Chemed Corp.'s stock price to reach $181.50 in the next twelve months. View Analyst Ratings for Chemed Corp..

Who are some of Chemed Corp.'s key competitors?

Who are Chemed Corp.'s key executives?

Chemed Corp.'s management team includes the folowing people:

  • George J. Walsh III, Independent Chairman of the Board
  • Kevin J. McNamara, President, Chief Executive Officer, Director
  • David Patrick Williams, Chief Financial Officer, Executive Vice President
  • Spencer S. Lee, Executive Vice President
  • Nicholas Michael Westfall, Executive Vice President
  • Michael D. Witzeman, Principal Accounting Officer, Controller
  • Thomas Charles Hutton, Director
  • Joel F. Gemunder, Independent Director
  • Patrick P. Grace, Independent Director
  • Walter L. Krebs, Independent Director

Who owns Chemed Corp. stock?

Chemed Corp.'s stock is owned by many different of retail and institutional investors. Top institutional shareholders include Riverbridge Partners LLC (4.17%), Acadian Asset Management LLC (3.60%), Fisher Asset Management LLC (3.11%), Van Berkom & Associates Inc. (2.77%), BTIM Corp. (1.11%) and Russell Investments Group Ltd. (0.91%). Company insiders that own Chemed Corp. stock include Arthur V Tucker Jr, David Patrick Williams, Donald E Saunders, George J Walsh III, Kevin J Mcnamara, Patrick P Grace and Spencer S Lee. View Institutional Ownership Trends for Chemed Corp..

Who sold Chemed Corp. stock? Who is selling Chemed Corp. stock?

Chemed Corp.'s stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, BTIM Corp., Russell Investments Group Ltd., Van Berkom & Associates Inc., Fisher Asset Management LLC, Rockefeller Financial Services Inc., Boston Advisors LLC and US Bancorp DE. Company insiders that have sold Chemed Corp. stock in the last year include Arthur V Tucker Jr, Donald E Saunders, Kevin J Mcnamara, Patrick P Grace and Spencer S Lee. View Insider Buying and Selling for Chemed Corp..

Who bought Chemed Corp. stock? Who is buying Chemed Corp. stock?

Chemed Corp.'s stock was bought by a variety of institutional investors in the last quarter, including Copeland Capital Management LLC, Acadian Asset Management LLC, NN Investment Partners Holdings N.V., State of Alaska Department of Revenue, Aperio Group LLC, Cape Cod Five Cents Savings Bank, First Quadrant L P CA and Parametrica Management Ltd. Company insiders that have bought Chemed Corp. stock in the last two years include Donald E Saunders and George J Walsh III. View Insider Buying and Selling for Chemed Corp..

How do I buy Chemed Corp. stock?

Shares of Chemed Corp. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Chemed Corp.'s stock price today?

One share of Chemed Corp. stock can currently be purchased for approximately $202.66.

MarketBeat Community Rating for Chemed Corp. (NYSE CHE)
Community Ranking:  2.0 out of 5 ( )
Outperform Votes:  73 (Vote Outperform)
Underperform Votes:  108 (Vote Underperform)
Total Votes:  181
MarketBeat's community ratings are surveys of what our community members think about Chemed Corp. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for Chemed Corp. (NYSE:CHE) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $181.50 (10.44% downside)

Analysts' Ratings History for Chemed Corp. (NYSE:CHE)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/5/2017Royal Bank Of CanadaReiterated RatingHold$208.00HighView Rating Details
9/27/2016Oppenheimer Holdings, Inc.Reiterated RatingOutperform$155.00N/AView Rating Details
9/4/2016JMP SecuritiesReiterated RatingHoldN/AView Rating Details
9/15/2015Deutsche Bank AGReiterated RatingBuyN/AView Rating Details
(Data available from 7/25/2015 forward)


Earnings History for Chemed Corp. (NYSE:CHE)
Earnings by Quarter for Chemed Corp. (NYSE:CHE)
Earnings History by Quarter for Chemed Corp. (NYSE CHE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/25/2017Q2 2017$1.89N/AView Earnings Details
4/26/2017Q1 2017$1.78$1.82$399.75 million$405.90 millionViewN/AView Earnings Details
2/15/2017Q416$2.10$2.10$409.89 million$403.00 millionViewListenView Earnings Details
10/26/2016Q316$1.82$1.73$270.44 million$392.61 millionViewListenView Earnings Details
7/25/2016Q216$1.72$1.80$393.50 million$290.00 millionViewListenView Earnings Details
4/28/2016Q116$1.58$1.62$391.68 million$390.40 millionViewListenView Earnings Details
2/17/2016Q415$1.81$1.97$390.22 million$398.60 millionViewListenView Earnings Details
10/22/2015Q315$1.61$1.78$375.95 million$386.23 millionViewListenView Earnings Details
7/23/2015Q215$1.59$1.71$375.01 million$382.00 millionViewListenView Earnings Details
4/28/2015Q115$1.35$1.54$370.76 million$377.00 millionViewListenView Earnings Details
2/17/2015Q414$1.65$1.80$372.54 million$379.00 millionViewListenView Earnings Details
10/30/2014Q314$1.34$1.40$360.00 million$358.40 millionViewListenView Earnings Details
7/23/2014Q214$1.31$1.50$363.73 million$360.18 millionViewListenView Earnings Details
4/29/2014Q114$1.23$1.32$256.77 million$358.30 millionViewListenView Earnings Details
10/29/2013Q313$1.34$1.36$355.40 million$340.90 millionViewListenView Earnings Details
7/18/2013Q2 2013$1.33$1.44$368.06 million$357.00 millionViewListenView Earnings Details
4/18/2013Q1 2013$1.29$1.38$365.08 million$367.00 millionViewListenView Earnings Details
2/18/2013Q4 2012$1.15$1.57$355.31 million$369.00 millionViewListenView Earnings Details
10/29/2012Q312$1.35$1.28$360.50 million$354.00 millionViewN/AView Earnings Details
7/25/2012$1.26$1.26ViewN/AView Earnings Details
4/19/2012$1.25$1.21ViewN/AView Earnings Details
2/14/2012$1.48$1.45ViewN/AView Earnings Details
10/25/2011$1.15$1.20ViewN/AView Earnings Details
4/26/2011$0.98$1.07ViewN/AView Earnings Details
2/15/2011$1.05$0.98ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Chemed Corp. (NYSE:CHE)
2017 EPS Consensus Estimate: $7.93
2018 EPS Consensus Estimate: $8.49
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171$1.77$1.77$1.77
Q2 20171$1.89$1.89$1.89
Q3 20171$1.96$1.96$1.96
Q4 20171$2.31$2.31$2.31
Q1 20181$1.92$1.92$1.92
Q2 20181$2.03$2.03$2.03
Q3 20181$2.10$2.10$2.10
Q4 20181$2.44$2.44$2.44
(Data provided by Zacks Investment Research)


Current Dividend Information for Chemed Corp. (NYSE:CHE)
Most Recent Dividend:6/14/2017
Annual Dividend:$1.04
Dividend Yield:0.51%
Dividend Growth:9.60% (3 Year Average)
Payout Ratio:15.25% (Trailing 12 Months of Earnings)
13.08% (Based on This Year's Estimates)
12.28% (Based on Next Year's Estimates)
Track Record:8 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Chemed Corp. (NYSE:CHE)

Dividend History by Quarter for Chemed Corp. (NYSE CHE)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Chemed Corp. (NYSE:CHE)
Insider Ownership Percentage: 5.32%
Institutional Ownership Percentage: 98.57%
Insider Trades by Quarter for Chemed Corp. (NYSE:CHE)
Institutional Ownership by Quarter for Chemed Corp. (NYSE:CHE)
Insider Trades by Quarter for Chemed Corp. (NYSE:CHE)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/26/2017George J Walsh IIIDirectorBuy1,000$204.56$204,560.00View SEC Filing  
5/4/2017Donald E SaundersDirectorBuy94$205.59$19,325.46View SEC Filing  
5/3/2017Donald E SaundersDirectorSell400$204.85$81,940.00View SEC Filing  
5/2/2017Kevin J McnamaraInsiderSell4,000$205.11$820,440.00View SEC Filing  
5/1/2017Spencer S LeeInsiderSell1,000$202.47$202,470.00View SEC Filing  
3/3/2017Kevin J McnamaraInsiderSell7,000$181.74$1,272,180.00View SEC Filing  
3/2/2017Arthur V Tucker JrVPSell2,266$181.00$410,146.00View SEC Filing  
2/27/2017Arthur V Tucker JrVPSell8,878$179.21$1,591,026.38View SEC Filing  
2/24/2017Kevin J McnamaraInsiderSell7,000$177.63$1,243,410.00View SEC Filing  
11/28/2016Patrick P GraceDirectorSell400$148.53$59,412.00View SEC Filing  
11/14/2016Donald E SaundersDirectorSell500$149.56$74,780.00View SEC Filing  
11/14/2016Spencer S LeeInsiderSell4,500$150.22$675,990.00View SEC Filing  
10/31/2016Kevin J McnamaraInsiderSell10,000$138.40$1,384,000.00View SEC Filing  
9/22/2016Spencer S LeeInsiderSell2,000$141.67$283,340.00View SEC Filing  
8/8/2016Donald E SaundersDirectorSell500$144.32$72,160.00View SEC Filing  
8/5/2016Arthur V Tucker JrVPSell4,500$144.28$649,260.00View SEC Filing  
8/4/2016Arthur V Tucker JrVPSell3,089$143.88$444,445.32View SEC Filing  
8/3/2016Kevin J McnamaraInsiderSell18,000$144.87$2,607,660.00View SEC Filing  
5/16/2016Donald E SaundersDirectorBuy77$126.53$9,742.81View SEC Filing  
3/21/2016Spencer S LeeEVPSell24,382$132.29$3,225,494.78View SEC Filing  
1/27/2016Patrick P GraceDirectorSell50$138.98$6,949.00View SEC Filing  
12/11/2015David Patrick WilliamsCFOSell5,000$151.72$758,600.00View SEC Filing  
11/24/2015Spencer S LeeEVPSell5,000$154.10$770,500.00View SEC Filing  
11/6/2015Kevin J McnamaraCEOSell6,000$157.02$942,120.00View SEC Filing  
10/27/2015Spencer S. LeeEVPSell4,000$153.64$614,560.00View SEC Filing  
10/26/2015Kevin J. McnamaraCEOSell8,000$149.04$1,192,320.00View SEC Filing  
8/24/2015David Patrick WilliamsCFOSell10,000$138.09$1,380,900.00View SEC Filing  
5/15/2015Arthur V Tucker JrVPSell9,000$121.00$1,089,000.00View SEC Filing  
5/7/2015Kevin J McnamaraCEOSell8,000$120.82$966,560.00View SEC Filing  
3/6/2015Spencer S LeeEVPSell9,931$115.16$1,143,653.96View SEC Filing  
3/2/2015Timothy S OtooleEVPSell10,000$117.82$1,178,200.00View SEC Filing  
2/27/2015Arthur V Tucker JrVPSell7,000$116.80$817,600.00View SEC Filing  
2/24/2015Arthur V Tucker JrVPSell2,685$114.35$307,029.75View SEC Filing  
2/23/2015Spencer S LeeEVPSell10,000$113.18$1,131,800.00View SEC Filing  
2/20/2015Kevin J McnamaraCEOSell13,000$112.71$1,465,230.00View SEC Filing  
11/14/2014Timothy S OtooleEVPSell5,000$106.81$534,050.00View SEC Filing  
11/13/2014Spencer S LeeEVPSell10,000$108.38$1,083,800.00View SEC Filing  
11/4/2014Kevin J McnamaraCEOSell4,000$104.13$416,520.00View SEC Filing  
9/10/2014Spencer S LeeEVPSell2,000$105.80$211,600.00View SEC Filing  
9/8/2014David Patrick WilliamsCFOSell5,000$105.90$529,500.00View SEC Filing  
8/7/2014Kevin J McnamaraCEOSell5,000$100.05$500,250.00View SEC Filing  
7/25/2014Arthur V Tucker JrVPSell9,000$101.26$911,340.00View SEC Filing  
7/25/2014Kevin J McnamaraCEOSell10,000$101.00$1,010,000.00View SEC Filing  
5/15/2014Timothy OtooleEVPSell9,000$87.62$788,580.00View SEC Filing  
5/5/2014Kevin McnamaraCEOSell5,000$85.05$425,250.00View SEC Filing  
4/2/2014Spencer LeeEVPSell2,000$90.15$180,300.00View SEC Filing  
3/19/2014Thomas HuttonVPSell2,201$88.36$194,480.36View SEC Filing  
3/11/2014Timothy OtooleEVPSell6,000$86.60$519,600.00View SEC Filing  
3/3/2014Kevin McnamaraCEOSell4,000$84.47$337,880.00View SEC Filing  
2/28/2014Arthur Tucker, Jr.VPSell9,000$85.01$765,090.00View SEC Filing  
2/25/2014Arthur Tucker, Jr.VPSell8,461$83.80$709,031.80View SEC Filing  
2/20/2014Spencer LeeEVPSell2,000$82.51$165,020.00View SEC Filing  
2/19/2014Kevin McnamaraCEOSell4,000$82.18$328,720.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Chemed Corp. (NYSE:CHE)
Latest Headlines for Chemed Corp. (NYSE:CHE)
DateHeadline logoChemed Reports Second-Quarter 2017 Results - July 25 at 5:05 PM logoETFs with exposure to Chemed Corp. : July 24, 2017 - July 24 at 4:44 PM logoChemed Corp. breached its 50 day moving average in a Bearish Manner : CHE-US : July 19, 2017 - July 19 at 3:42 PM logoChemed Corp. (NYSE:CHE) to Release Earnings on Tuesday - July 18 at 8:36 AM logoETFs with exposure to Chemed Corp. : July 13, 2017 - July 13 at 6:11 PM logoChemed Corp. – Value Analysis (NYSE:CHE) : July 10, 2017 - July 10 at 5:05 PM logoChemed To Report Second-Quarter 2017 Earnings July 25, Related Conference Call To Be Held On July 26 - July 10 at 5:05 PM logoChemed Corp. breached its 50 day moving average in a Bearish Manner : CHE-US : July 7, 2017 - July 8 at 9:45 AM logoChemed Corp. (NYSE:CHE) Given "Hold" Rating at Royal Bank Of Canada - July 5 at 9:20 PM logoChemed Corp. (CHE) Director Acquires $204,560.00 in Stock - June 26 at 1:22 PM logoChemed Corp. (CHE) Rating Lowered to Buy at BidaskClub - June 24 at 2:26 PM logoNew COO takes over at Cincinnati-owned health care firm - June 20 at 4:54 PM logoChemed Corp. (CHE) and Almost Family (AFAM) Head to Head Comparison - June 13 at 7:45 AM logoHead-To-Head Review: Amedisys (AMED) & Chemed (CHE) - June 4 at 4:50 PM logoChemed Corporation to Present at the Jefferies 2017 Global Healthcare Conference - May 31 at 4:19 PM logoChemed Co. (che) to Issue $0.26 Quarterly Dividend - May 16 at 10:22 AM logoChemed Corporation Holds Annual Meeting of Shareholders; Board Declares Quarterly Dividend - May 15 at 4:01 PM logoChemed Corporation to Present at the Bank of America Merrill Lynch 2017 Health Care Conference - May 11 at 4:54 PM logoInsider Buying: Chemed Co. (CHE) Director Acquires 94 Shares of Stock - May 5 at 5:14 PM logoChemed Co. (CHE) Director Sells $81,940.00 in Stock - May 5 at 4:51 PM logoFavorable News Coverage Unlikely to Affect Chemed (CHE) Share Price - May 4 at 5:14 PM logoChemed Co. (CHE) Insider Sells $820,440.00 in Stock - May 2 at 6:46 PM logoSpencer S. Lee Sells 1,000 Shares of Chemed Co. (CHE) Stock - May 1 at 8:24 PM logoChemed Corp. :CHE-US: Earnings Analysis: Q1, 2017 By the Numbers : May 1, 2017 - May 1 at 4:14 PM logoOppenheimer Holdings Weighs in on Chemed Co.'s Q3 2018 Earnings (CHE) - May 1 at 1:04 PM logoFavorable Press Coverage Somewhat Unlikely to Affect Chemed (CHE) Stock Price - April 29 at 5:47 PM logoEdited Transcript of CHE earnings conference call or presentation 27-Apr-17 2:00pm GMT - April 28 at 5:14 PM logoChemed Reports First-Quarter 2017 Results - April 27 at 4:43 PM logoChemed Co. (CHE) Posts Quarterly Earnings Results, Beats Estimates By $0.03 EPS - April 27 at 12:20 AM logoChemed Co. (CHE) Announces Earnings Results - April 26 at 11:24 PM logoChemed (CHE) Earns Daily News Sentiment Score of 0.34 - April 26 at 9:00 PM logoChemed Co. (CHE) Releases FY17 Earnings Guidance - April 26 at 6:49 PM logoChemed posts 1Q profit - April 26 at 6:28 PM logoChemed (CHE) Given Daily News Impact Rating of 0.31 - April 20 at 4:11 PM logoEXCLUSIVE: How Facebook fueled the Courier's stock contest leader - April 17 at 4:06 PM logoChemed (CHE) Earning Somewhat Critical News Coverage, Study Finds - April 17 at 2:54 PM logoChemed (CHE) Earns Media Impact Score of 0.50 - April 14 at 9:21 AM logoChemed (CHE) Board of Directors Initiates Share Buyback Plan - April 10 at 9:14 AM logoChemed To Report First-Quarter 2017 Earnings April 26, Related Conference Call To Be Held On April 27 - April 7 at 8:58 AM logoCHEMED CORP Files SEC form 8-K, Change in Directors or Principal Officers - April 3 at 4:40 PM logoChemed (CHE) Up 6.4% Since Earnings Report: Can It Continue? - March 21 at 8:01 AM logoChemed Corporation to Present at the Oppenheimer 27th Annual Healthcare Conference - March 15 at 4:38 PM logo8:30 am Chemed's Board authorizes an additional $100 million for stock repurchase under its existing share repurchase program - March 13 at 12:43 PM logoChemed Corporation’s Board of Directors Authorizes an Additional $100 Million for Stock Repurchase - March 13 at 12:43 PM logoCHEMED CORP Files SEC form 8-K, Other Events - March 13 at 12:43 PM logoCHEMED CORP Financials - March 3 at 4:17 PM logoCHEMED CORP Files SEC form 10-K, Annual Report - February 27 at 2:49 PM logoEdited Transcript of CHE earnings conference call or presentation 16-Feb-17 3:00pm GMT - February 17 at 5:56 PM logoChemed Corp. :CHE-US: Earnings Analysis: Q4, 2016 By the Numbers : February 17, 2017 - February 17 at 5:56 PM logoCHEMED CORP Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year - February 17 at 5:56 PM



Chemed Corp. (CHE) Chart for Tuesday, July, 25, 2017

This page was last updated on 7/25/2017 by Staff